Targeted Therapy Substantially Decreases Progression Rate In Patients With An...
The drug pazopanib may help revolutionize the care of patients with metastatic, rapidly progressive differentiated thyroid cancers, say researchers at Mayo Clinic who are publishing findings of a phase...
View ArticleTargeted Therapy Decreases Progression Rate In Thyroid Cancer
The drug pazopanib may help revolutionize the care of patients with metastatic, rapidly progressive differentiated thyroid cancers, say researchers at Mayo Clinic who are publishing findings of a phase...
View ArticlePazopanib Shows Promise In Phase II Trial For Relapsed/Refractory Urothelial...
An ongoing Phase-II trial investigating a new, targeted therapy for metastatic urothelial cancer has generated promising early results, Italian researchers reported at the 35th Congress of the European...
View ArticleAdvanced Kidney Cancer Patients Now Able To Access Votrient® – (Pazopanib) On...
From today, patients living in Scotland with advanced renal cell carcinoma, a type of kidney cancer, will have access to a new treatment choice, as Votrient® (pazopanib) is made available on the...
View Article
